Login / Signup

Using in silico viral kinetic models to guide therapeutic strategies during a pandemic: An example in SARS-CoV-2.

Kashyap PatelMichael DoddsAntonio GonçalvesMohamed A KamalCraig R RaynerCarl M J KirkpatrickPatrick F Smith
Published in: British journal of clinical pharmacology (2021)
The use of in silico models can provide viral load predictions that can rationalize therapeutic strategies against an emerging viral pathogen.
Keyphrases
  • sars cov
  • molecular docking
  • respiratory syndrome coronavirus
  • molecular dynamics simulations